Abstract
Fluorescence photobleaching and photoproduct formation were investigated during δ-aminolevulinic acid (ALA) induced protoporphyrin IX (PpIX) PDT of MLL cells in vitro. Cells were incubated in either 0.1 or 1.0 mM ALA for 4 h and were treated with 532 nm or 635 nm light under well oxygenated or hypoxic conditions. Fluorescence spectra were acquired during treatment. Photobleaching and photoproduct formation were quantified using singular value decomposition fitting of fluorescence spectra to experimentally determined basis spectra for PpIX, photoprotoporphyrin (Ppp), product II (peak at 655 nm), and product III (peak at 618 nm). PpIX photobleaching occurred under both normal and hypoxic conditions. The photobleaching kinetics could not be explained by purely first- or second-order photobleaching kinetics, and were attributed to differences in PpIX binding at the two ALA incubation concentrations. Ppp was the main photoproduct and accumulated in higher levels in the absence of oxygen, likely a result of reduced Ppp photobleaching under hypoxia. Increases in product II fluorescence occurred mainly in the presence of oxygen. To assess potential fluorescence based PDT dose metrics, cell viability was measured at select times during treatment using a colony formation assay. Cell survival correlated well to changes in product II fluorescence, independent of oxygenation, sensitizer concentration, and treatment wavelength, suggesting that this product is primarily a result of singlet oxygen mediated reactions and may potentially be useful to quantify singlet oxygen dose during PDT.
Similar content being viewed by others
References
H. Fukuda, A. Casas and A. Batlle, Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy, Int. J. Biochem. Cell Biol., 2005, 37, 272–276.
B. Krammer and K. Uberriegler, In-vitro investigation of ALA-induced protoporphyrin IX, J. Photochem. Photobiol., B, 1996, 36, 121–126.
J. C. Kennedy, R. H. Pottier and D. C. Pross, Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience, J. Photochem. Photobiol., B, 1990, 6, 143–148.
L. Wyld, M. W. Reed and N. J. Brown, The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro, Br. J. Cancer, 1998, 77, 1621–1627.
P. Uehlinger, M. Zellweger, G. Wagnieres, L. Juillerat-Jeanneret, H. van den Bergh and N. Lange, 5-Aminolevulinic acid and its derivatives: physical chemical properties and protoporphyrin IX formation in cultured cells, J. Photochem. Photobiol., B, 2000, 54, 72–80.
I. Georgakoudi, P. C. Keng and T. H. Foster, Hypoxia significantly reduces aminolaevulinic acid-induced protoporphyrin IX synthesis in EMT6 cells, Br. J. Cancer, 1999, 79, 1372–7.
A. Juzeniene, P. Juzenas, O. Kaalhus, V. Iani and J. Moan, Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin, Photochem. Photobiol., 2002, 76, 452–456.
W. Dietel, K. Bolsen, E. Dickson, C. Fritsch, R. Pottier and R. Wendenburg, Formation of water-soluble porphyrins and protoporphyrin IX in 5-aminolevulinic-acid-incubated carcinoma cells, J. Photochem. Photobiol., B, 1996, 33, 225–231.
L. Wyld, J. L. Burn, M. W. Reed and N. J. Brown, Factors affecting aminolaevulinic acid-induced generation of protoporphyrin IX, Br. J. Cancer, 1997, 76, 705–712.
I. A. Boere, D. J. Robinson, H. S. de Bruijn, J. van den Boogert, H. W. Tilanus, H. J. Sterenborg and R. W. de Bruin, Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy, Photochem. Photobiol., 2003, 78, 271–277.
M. J. Niedre, A. J. Secord, M. S. Patterson and B. C. Wilson, In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy, Cancer Res., 2003, 63, 7986–7994.
J. S. Dysart, G. Singh and M. S. Patterson, Calculation of Singlet Oxygen Dose from Photosensitizer Fluorescence and Photobleaching During mTHPC Photodynamic Therapy of MLL Cells, Photochem. Photobiol., 2005, 81, 196–205.
J. S. Dysart and M. S. Patterson, Characterization of Photofrin photobleaching for singlet oxygen dose estimation during photodynamic therapy of MLL cells in vitro, Phys. Med. Biol., 2005, 50, 2597–2616.
J. S. Dysart, M. S. Patterson, T. J. Farrell and G. Singh, Relationship between mTHPC fluorescence photobleaching and cell viability during in vitro photodynamic treatment of DP16 cells, Photochem. Photobiol., 2002, 75, 289–295.
L. Brancaleon and H. Moseley, Effects of photoproducts on the binding properties of protoporphyrin IX to proteins, Biophys. Chem., 2002, 96, 77–87.
J. Moan, G. Streckyte, S. Bagdonas, O. Bech and K. Berg, Photobleaching of protoporphyrin IX in cells incubated with 5-aminolevulinic acid, Int. J. Cancer, 1997, 70, 90–97.
L. Brancaleon, S. W. Magennis, I. D. Samuel, E. Namdas, A. Lesar and H. Moseley, Characterization of the photoproducts of protoporphyrin IX bound to human serum albumin and immunoglobulin G, Biophys. Chem., 2004, 109, 351–360.
A. Datta, A. Dube, B. Jain, A. Tiwari, P. K. Gupta, The effect of pH and surfactant on the aggregation behavior of chlorin p6: a fluorescence spectroscopic study, Photochem. Photobiol., 2002, 75, 488–494.
L. Bezdetnaya, N. Zeghari, I. Belitchenko, M. Barberi-Heyob, J. L. Merlin, A. Potapenko and F. Guillemin, Spectroscopic and biological testing of photobleaching of porphyrins in solutions, Photochem. Photobiol., 1996, 64, 382–386.
C. D. Sudworth, M. R. Stringer, J. E. Cruse-Sawyer and S. B. Brown, Fluorescence microspectroscopy technique for the study of intracellular protoporphyrin IX dynamics, Appl. Spectrosc., 2003, 57, 682–688.
W. S. Strauss, R. Sailer, M. H. Gschwend, H. Emmert, R. Steiner and H. Schneckenburger, Selective examination of plasma membrane-associated photosensitizers using total internal reflection fluorescence spectroscopy: correlation between photobleaching and photodynamic efficacy of protoporphyrin IX, Photochem. Photobiol., 1998, 67, 363–369.
S. Bagdonas, L. W. Ma, V. Iani, R. Rotomskis, P. Juzenas and J. Moan, Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study, Photochem. Photobiol., 2000, 72, 186–192.
R. Sorensen, V. Iani and J. Moan, Kinetics of photobleaching of protoporphyrin IX in the skin of nude mice exposed to different fluence rates of red light, Photochem. Photobiol., 1998, 68, 835–840.
P. Juzenas, S. Sharfaei, J. Moan and R. Bissonnette, Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester, J. Photochem. Photobiol., B, 2002, 67, 11–17.
M. B. Ericson, S. Grapengiesser, F. Gudmundson, A. M. Wennberg, O. Larko, J. Moan and A. Rosen, A spectroscopic study of the photobleaching of protoporphyrin IX in solution, Lasers Med. Sci., 2004, 18, 56–62.
K. Konig, H. Schneckenburger, A. Ruck and R. Konig, Studies on porphyrin photoproducts in solution, cells, and tumor tissue, Proc. SPIE-Int. Soc. Opt. Eng., 1994, 2133, 226–237.
W. Dietel, C. Fritsch, R. H. Pottier and R. Wendenburg, 5-Aminolaevulinic-acid-induced formation of different porphyrins and their photomodifications, Lasers Med. Sci., 1997, 12, 266–236.
J. C. Finlay, D. L. Conover, E. L. Hull and T. H. Foster, Porphyrin bleaching and PDT-induced spectral changes are irradiance dependent in ALA-sensitized normal rat skin in vivo, Photochem. Photobiol., 2001, 73, 54–63.
D. J. Robinson, H. S. de Bruijn, N. van der Veen, M. R. Stringer, S. B. Brown and W. M. Star, Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin, Photochem. Photobiol., 1999, 69, 61–70.
G. S. Cox, C. Bobillier and D. G. Whitten, Photooxidation and singlet oxygen sensitization by protoporphyrin IX and its photooxidation products, Photochem. Photobiol., 1982, 36, 401–407.
D. E. Gudgin and R. H. Pottier, On the role of protoporphyrin IX photoproducts in photodynamic therapy, J. Photochem. Photobiol., B, 1995, 29, 91–93.
L. Ma, S. Bagdonas and J. Moan, The photosensitizing effect of the photoproduct of protoporphyrin IX, J. Photochem. Photobiol., B, 2001, 60, 108–113.
T. Theodossiou and A. J. MacRobert, Comparison of the photodynamic effect of exogenous photoprotoporphyrin and protoporphyrin IX on PAM 212 murine keratinocytes, Photochem. Photobiol., 2002, 76, 530–537.
P. Juzenas, V. Iani, S. Bagdonas, R. Rotomskis and J. Moan, Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light, J. Photochem. Photobiol., B, 2001, 61, 78–86.
S. L. Gibson, J. J. Havens, M. L. Nguyen and R. Hilf, Delta-aminolaevulinic acid-induced photodynamic therapy inhibits protoporphyrin IX biosynthesis and reduces subsequent treatment efficacy in vitro, Br. J. Cancer, 1999, 80, 998–1004.
D. Kessel, Relocalization of cationic porphyrins during photodynamic therapy, Photochem. Photobiol. Sci., 2002, 1, 837–840.
H. Zeng, M. Korbelik, D. I. McLean, C. MacAulay and H. Lui, Monitoring photoproduct formation and photobleaching by fluorescence spectroscopy has the potential to improve PDT dosimetry with a verteporfin-like photosensitizer, Photochem. Photobiol., 2002, 75, 398–405.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dysart, J.S., Patterson, M.S. Photobleaching kinetics, photoproduct formation, and dose estimation during ALA induced PpIX PDT of MLL cells under well oxygenated and hypoxic conditions. Photochem Photobiol Sci 5, 73–81 (2006). https://doi.org/10.1039/b511807g
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/b511807g